Triplepoint Venture Growth BDC Corp
Change company Symbol lookup
Select an option...
TPVG Triplepoint Venture Growth BDC Corp
RVNC Revance Therapeutics Inc
ZFGN Zafgen Inc
SFOR StrikeForce Technologies Inc
SPLV Invesco S&P 500® Low Volatility ETF
USMV iShares Edge MSCI Min Vol USA ETF
HULYX Hawaiian Tax-Free Trust Class Y
ORNCD Oranco Inc
ATGE Adtalem Global Education Inc
NUV Nuveen Municipal Value Fund
Go

Financials : Capital Markets | Small Cap BlendCompany profile

TriplePoint Venture Growth BDC Corp. is a closed-end, non-diversified management investment company. The Company's investment objective is to maximize its total return to stockholders primarily in the form of current income and, to a lesser extent, capital appreciation by primarily lending with warrants to venture growth stage companies focused in technology, life sciences and other high growth industries, which are backed by TriplePoint Capital LLC's (TPC) select group of venture capital investors. The Company targets investment opportunities in venture growth stage companies backed by venture capital investors. The Company originates and invests primarily in loans that have a secured collateral position and are used by venture growth stage companies to finance their continued expansion and growth, equipment financings and, on a select basis, revolving loans. The Company is managed by TPVG Advisers LLC.

Closing Price
$16.40
Day's Change
-0.03 (-0.18%)
Bid
--
Ask
--
B/A Size
--
Day's High
16.49
Day's Low
16.30
Volume
(Light)
Volume:
170,315

10-day average volume:
240,879
170,315

UPDATE: Corona-parent Constellation Brands to record $106 million loss as its share of Canopy Growth's losses

12:42 pm ET June 21, 2019 (MarketWatch)
Print

Shares of Constellation Brands Inc. (STZ) eased 0.1% in morning trading Friday, after the owner of Corona and Modela beer and Svedka vodka brands disclosed that it's share of Canopy Growth Corp.'s (WEED.T) fiscal fourth-quarter losses comes to $106 million, or $78.2 million after including tax benefits. The company, which owns a 35.8% stake (http://www.marketwatch.com/story/constellation-brands-makes-additional-4-billion-investment-in-cannabis-company-canopy-growth-2018-08-15) in Canada-based cannabis company Canopy, said it recognizes equity in earnings from its equity-method investment in Canopy on a 2-month lag. Canopy reported late Thursday a fourth-quarter net loss of C$323.4 million (http://www.marketwatch.com/story/canopy-growth-earnings-show-decline-in-recreational-pot-sales-from-launch-of-legal-weed-in-canada-2019-06-20) ($244.8 million). Constellation said it expects to record those losses in its fiscal first-quarter, which ended in May. Constellation's stock has gained 9.6% over the past three months, while the U.S.-listed shares of Canopy have shed 10.0% and the S&P 500 has gained 3.4%.

-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

June 21, 2019 12:42 ET (16:42 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.